(Q34774421)

4 August 2017

1 reference

title

Chronic heart failure: an example of a systemic chronic inflammatory disease resulting in cachexia (English)

1 reference

4 August 2017

0 references

0 references

chronic heart failure

1 reference

Viviane M Conraads

1

1 reference

4 August 2017

Johan M Bosmans

series ordinal

2

1 reference

4 August 2017

Christiaan J Vrints

series ordinal

3

1 reference

4 August 2017

publication date

1 September 2002

1 reference

International Journal of Cardiology

4 August 2017

published in

1 reference

4 August 2017

volume

85

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

33-49

1 reference

Alterations of skeletal muscle in chronic heart failure

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Skeletal Muscle Function and Its Relation to Exercise Tolerance in Chronic Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

A neural link to explain the "muscle hypothesis" of exercise intolerance in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Plasma cytokine parameters and mortality in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

The Denolin lecture. Congestive heart failure: a half century perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

STUDIES ON STARLING'S LAW OF THE HEART. IX. THE EFFECTS OF IMPEDING VENOUS RETURN ON PERFORMANCE OF THE NORMAL AND FAILING HUMAN LEFT VENTRICLE

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Catecholamine cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Increased resting metabolic rate in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Correlates and prognostic implication of exercise capacity in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Acute and long-term effects of vasodilator therapy on resting and exercise hemodynamics and exercise tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Cardiorespiratory responses of cardiac transplant patients to graded, symptom-limited exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Endothelium-dependent vasodilation is attenuated in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Alterations in vasomotor tone in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Endothelial function in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Endothelial dysfunction in patients with chronic heart failure: systemic effects of lower-limb exercise training

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Physical training improves endothelial function in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Neuroendocrine activation in heart failure is modified by endurance exercise training

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Suppression of angiotensin-converting enzyme expression and activity by shear stress

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Physical training reduces peripheral markers of inflammation in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Increased oxidative stress in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Relation of systemic and local muscle exercise capacity to skeletal muscle characteristics in men with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Safety and effects of physical training in chronic heart failure. Results of the Chronic Heart Failure and Graded Exercise study (CHANGE)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Physical training improves skeletal muscle metabolism in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Wasting as independent risk factor for mortality in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Cardiac cachexia is a world-wide problem

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Uric acid in chronic heart failure: a marker of chronic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Hyperleptinaemia in chronic heart failure. Relationships with insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Symptoms and quality of life in heart failure: the muscle hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Contribution of skeletal muscle 'ergoreceptors' in the human leg to respiratory control in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Ventilatory and heart rate responses to exercise : better predictors of heart failure mortality than peak oxygen consumption

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Impairment of ventilatory efficiency in heart failure: prognostic impact

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Ventilation in chronic heart failure: effects of physical training

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Peripheral and respiratory muscles in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

The tumor necrosis factor ligand and receptor families.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

TNF-Induced shedding of TNF receptors in human polymorphonuclear leukocytes: role of the 55-kDa TNF receptor and involvement of a membrane-bound and non-matrix metalloproteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Influence of a Myocardial Depressant Factor on Physiologic Properties of Cardiac Muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Cytokines and cardiac contractile function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Increased inducible nitric oxide synthase in skeletal muscle biopsies from patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Cardiac-specific overexpression of tumor necrosis factor-alpha causes oxidative stress and contractile dysfunction in mouse diaphragm

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Cytokines and endothelial cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Cytokine regulation of endothelial cell function.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

How are cytokines activated in heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Serum complement activation in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Relative lymphocyte count: a prognostic indicator of mortality in elderly patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Elevated tumor necrosis factor alpha of blood mononuclear cells in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Cytokine generation capacities of monocytes are reduced in patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Activation of the cardiac interleukin-6 system in advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Interleukin-1 in Myocardium and Coronary Arteries of Patients with Dilated Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

LPS induction of gene expression in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Elevated soluble CD14 receptors and altered cytokines in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Evidence for increased peripheral production of tumor necrosis factor-alpha in advanced congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. Prospective Randomized Amlodipine Survival Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Amiodarone inhibits production of tumor necrosis factor-alpha by human mononuclear cells: a possible mechanism for its effect in heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Effects of amiodarone on tumor necrosis factor-alpha levels in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Pimobendan inhibits the activation of transcription factor NF-kappaB: a mechanism which explains its inhibition of cytokine production and inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900232-2

7 January 2021

10.1016/S0167-5273(02)00232-2

Identifiers

DOI

1 reference

4 August 2017

1 reference